Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 6Lymphoid 6Genitourinary 3Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Classical hematology 1Breast 1

Conditions

Leukemia, Myeloid, Acute 1539Leukemia 1389Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Leukemia, Lymphocytic, Chronic, B-Cell 1090Myelodysplastic Syndromes 722Lymphoma 658Lymphoma, Non-Hodgkin 627Hematologic Neoplasms 554Lymphoma, Follicular 487Leukemia, Myelogenous, Chronic, BCR-ABL Positive 469Lymphoma, Mantle-Cell 459Lymphoma, Large B-Cell, Diffuse 444Burkitt Lymphoma 432Hodgkin Disease 431Lymphoma, B-Cell, Marginal Zone 424Multiple Myeloma 415Lymphoma, Large-Cell, Immunoblastic 335Leukemia, Myelomonocytic, Chronic 314Congenital Abnormalities 287Recurrence 279Leukemia, Myeloid, Chronic-Phase 272Myeloproliferative Disorders 260Neoplasms 256Blast Crisis 249Waldenstrom Macroglobulinemia 232Leukemia, Myeloid, Accelerated Phase 216Lymphoma, T-Cell, Cutaneous 213Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Mycosis Fungoides 183Lymphoma, Large-Cell, Anaplastic 181

Interventions

Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Vascular Diseases × Other hematologic neoplasm × Clear all
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡